NDC 63459-305

HERZUMA

Trastuzumab

HERZUMA is a Kit in the Human Prescription Drug category. It is labeled and distributed by Cephalon, Inc.. The primary component is .

• Product ID: 63459-305_1319744e-b28e-4f84-80f7-388bb637f5db
• NDC: 63459-305
• Product Type: Human Prescription Drug
• Proprietary Name: HERZUMA
• Generic Name: Trastuzumab
• Dosage Form: Kit
• Marketing Start Date: 2018-12-14
• Marketing Category: BLA / BLA
• Application Number: BLA761091
• Labeler Name: Cephalon, Inc.
• Active Ingredient Strength: 0
• NDC Exclude Flag: N
• Listing Certified Through: 2020-12-31

Packaging

NDC 63459-305-47

1 KIT in 1 CARTON (63459-305-47) * 50 mL in 1 VIAL, MULTI-DOSE (63459-307-41) * 20 mL in 1 VIAL (63459-221-20)

• Marketing Start Date: 2020-03-16
• NDC Exclude Flag: N
• Sample Package?: N

NDC SPL Data Element Entries

NDC 63459-305-47 [63459030547]

HERZUMA KIT

• Marketing Category: BLA
• Application Number: BLA761091
• Product Type: HUMAN PRESCRIPTION DRUG
• Billing Unit: EA
• Marketing Start Date: 2020-03-16

Drug Details

OpenFDA Data

• SPL SET ID: ae71c003-883a-4cd8-ad50-e8cc9a54e971
• Manufacturer:
  • Cephalon, Inc.
• RxNorm Concept Unique ID - RxCUI:
  • 2107058
  • 2107053

NDC Crossover Matching brand name "HERZUMA" or generic name "Trastuzumab"

NDC	Brand Name	Generic Name
63459-303	HERZUMA	TRASTUZUMAB
63459-305	HERZUMA	TRASTUZUMAB
50242-132	Herceptin	Trastuzumab
50242-134	Herceptin	Trastuzumab
50242-333	Herceptin	Trastuzumab
67457-845	OGIVRI	trastuzumab
67457-847	OGIVRI	trastuzumab
67457-991	OGIVRI	trastuzumab
0006-5033	Ontruzant	trastuzumab
0069-0305	Trazimera-qyyp	trastuzumab